Immunohistochemical Expression
Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists' practice, that allows identifying diagnostic and prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_76432 | ||
005 | 20220111 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220111s2021 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-0401-8 | ||
020 | |a 9783036504001 | ||
020 | |a 9783036504018 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-0401-8 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Caltabiano, Rosario |4 edt | |
700 | 1 | |a Loreto, Carla |4 edt | |
700 | 1 | |a Caltabiano, Rosario |4 oth | |
700 | 1 | |a Loreto, Carla |4 oth | |
245 | 1 | 0 | |a Immunohistochemical Expression |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
300 | |a 1 electronic resource (168 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists' practice, that allows identifying diagnostic and prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee the visualization of an antibody-antigene binding complex under a light microscope [1]. Coon et al., in 1941 [2], first introduced the use of fluorochrome-conjugated antibodies in clinical practice. Since then, IHC has gone from being a useful tool for identifying the differentiation line of otherwise undifferentiated cells to a technique capable of providing not only diagnostic but also prognostic and predictive indications of responses to specific therapeutic options [1,3]. The abovementioned peculiarities have made IHC one of the most used ancillary methods in the histopathological approach to human neoplastic and non-neoplastic diseases [3-5]. This Special Issue contains 11 accepted papers that provide readers with a comprehensive update on current and future applications of IHC in medical practice. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a training exercise | ||
653 | |a NGAL | ||
653 | |a VDR | ||
653 | |a kidney | ||
653 | |a heart | ||
653 | |a immunohistochemistry | ||
653 | |a ABCB5 | ||
653 | |a uveal melanoma | ||
653 | |a prognosis | ||
653 | |a metastasis | ||
653 | |a pericardium | ||
653 | |a cytokeratin | ||
653 | |a c-kit | ||
653 | |a PDGFR | ||
653 | |a initial lymphatics | ||
653 | |a macroH2A | ||
653 | |a prognostic factor | ||
653 | |a SLC22A12 | ||
653 | |a URAT1 | ||
653 | |a hypouricemia | ||
653 | |a uric acid transporters | ||
653 | |a excretion fraction of uric acid | ||
653 | |a Hsp27 | ||
653 | |a Hsp60 | ||
653 | |a Hsp70 | ||
653 | |a Hsp90 | ||
653 | |a molecular chaperone | ||
653 | |a chaperonopathies | ||
653 | |a thyroid | ||
653 | |a follicular adenoma | ||
653 | |a follicular carcinoma | ||
653 | |a differential diagnosis | ||
653 | |a carcinogenesis | ||
653 | |a matrix metalloproteinases | ||
653 | |a temporomandibular joint disorder | ||
653 | |a temporomandibular joint | ||
653 | |a DEN | ||
653 | |a liver | ||
653 | |a inflammation | ||
653 | |a ultra-structural changes | ||
653 | |a oxidative stress | ||
653 | |a EGCG | ||
653 | |a Vitamin D | ||
653 | |a prostate cancer | ||
653 | |a urinary tract malformations | ||
653 | |a megacystis | ||
653 | |a enteric nervous system | ||
653 | |a outcome and prognosis | ||
653 | |a WT1 | ||
653 | |a human embryonal/fetal tissues | ||
653 | |a neoplastic tissue | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/3867 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/76432 |7 0 |z DOAB: description of the publication |